Picture of Scandinavian ChemoTech AB logo

CMOTEC B Scandinavian ChemoTech AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Scandinavian Chemotech Gets New Approval In Japan For Its TSE For Deep Seated Tumours

March 24 (Reuters) - Scandinavian ChemoTech AB
 CMOTECb.ST :
    * SCANDINAVIAN CHEMOTECH RECEIVES NEW APPROVAL IN JAPAN FOR
ITS
TSE FOR DEEP SEATED TUMOURS
    * PATENT PROTECTS INNOVATION USED FOR TSE THERAPY IN DEEP
SEATED
TUMOURS AND SECONDARY BONE CANCER

Source text for Eikon:  ID:nWkr5cvlrD 
Further company coverage:  CMOTECb.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Scandinavian ChemoTech AB

See all news